» 산업 뉴스 » China to Balance COVID-19 Fight and Economic Development

COVID-19 싸움과 경제 발전의 균형을 맞추는 중국

2022-08-22

A medical worker takes a swab sample from a resident for nucleic acid testing in Jilin city, Jilin province, 6월 21, 2022.

China’s fight against the COVID-19 epidemic has entered the stage that stresses striking a balance between disease control and social and economic development, Li Bin, vice-minister of the National Health Commission, said on Saturday.

He said global COVID-19 counts remain high and new mutations are emerging, threatening to trigger more sporadic infections and local outbreaks in China.

Li said China will combine regular disease containment measures with emergency response in virus-hit regions, and make its virus control work more precise, efficient and scientific.

He spoke at the 2022 National Vaccines and Health Conference held in Beijing. The conference will last for a week.

Li added that the mainland has administered over 3.4 billion COVID-19 vaccines and fully vaccinated 89 percent of its total population.

More systematic research is needed on the immunogenicity and immunity persistence of vaccines and their protection effects in the long term. Close attention should also be paid to study emerging variantseffects on existing doses, and preparedness and R&D should be launched to create variant-specific vaccines,” 그는 말했다.

In the meantime, he called for sustaining routine vaccination campaigns, and ensuring that the vaccination rate of children eligible for the national immunization program remains above 90 퍼센트.

Shen Hongbin, deputy head of the National Administration of Disease Prevention and Control and director of the Chinese Center for Disease Control and Prevention, said that China has made significant progress in vaccination drives in recent years.

현재, 약 있다 80,000 routine vaccination stations. During the peak of COVID-19 vaccination, ~에 대한 216,000 new vaccination facilities were added, leading to a record number of doses delivered in one day at 25 백만.

The information system for vaccination and monitoring mechanism for adverse effects have also been established and improved in recent years, 그는 덧붙였다.

 

원천: 차이나 데일리

어쩌면 당신도 좋아

  • 카테고리

  • 최근 게시물

  • 태그

  • 회사 소개


    메디컬 테크놀로지(주), 주식회사. 중국의 의료 용품 전문 제조업체입니다., 우리는 나일론 무리를 지어 면봉을 생산하고 판매합니다, VTM 키트, 타액 수집 키트 및 CHG 면봉 & 델타 변종에 효과적인 중국에서 가장 많이 사용되는 COVID-19 백신.

  • 문의하기

    주소: 방 201, 301 그리고 401 A동 10호, 바오롱 5번가, 통글 커뮤니티, 바오롱 스트리트, 롱강 지구,선전, 광동, 중국.

    편물: www.medicoswab.com

    전화 번호: +86 0755-28997664

    이메일: info@medicoswab.com